News

Centre permits revised MRPs on unsold stock after GST changes till 31 Dec 2025, subject to conditions on stamping, display, and consumer ...
New Delhi, Sep 13 (PTI) The National Pharmaceutical Pricing Authority has asked pharmaceutical companies and medical device makers to pass on the benefit of reduced GST rates to consumers with effect ...
The government has mandated pharma companies to revise the Maximum Retail Price (MRP) of medicines, formulations, and medical ...
The GST Council has revised rates of a range of fast-moving consumer goods (FMCG), effective from September 22, reducing them ...
The Department of Consumer Affairs has asked the industry—manufacturers, packers and importers—to place at least two ...
Separately, the finance ministry is studying mechanisms to help businesses deal with potential losses from new inverted duty ...
Jharkhand DC issues guidelines on MRP revisions of medicines post-GST amendments: Peethaambaran Kunnathoor, Chennai Thursday, September 11, 2025, 08:00 Hrs [IST] In response to th ...
The government has allowed companies that released stock before September 22 to neither recall it nor put new labels on it.
The Department of Consumer Affairs has allowed manufacturers, packers and importers to revise MRP on unsold stock using ...
NPPA directs pharma, medical devices industries to implement GST cut: Our Bureau, New Delhi Saturday, September 13, 2025, 13:40 Hrs [IST] The National Pharmaceutical Pricing Autho ...
The NPPA has directed drug manufacturers to revise MRPs in line with GST rate cuts, ensuring the benefit reaches consumers.